Kraj: Australia
Język: angielski
Źródło: Department of Health (Therapeutic Goods Administration)
Japanese encephalitis virus
CSL Limited
Medicine Registered
JESPECT ® (jess-pect) JAPANESE ENCEPHALITIS VACCINE, INACTIVATED, ADSORBED Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about JESPECT ® . It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines, including vaccines, have risks and benefits. Your doctor has weighed the risks of you having JESPECT ® against the benefits they expect it will have. If you have any concerns about this vaccine, talk to your doctor, nurse or pharmacist. Keep this leaflet. You might need to read it again. What JESPECT ® is used for JESPECT ® is a vaccine. It helps prevent Japanese encephalitis (en-kef-al-i-tis) , a severe and often fatal infection of the brain. Some of those who recover from the disease are often left with brain damage. Japanese encephalitis is caused by the Japanese encephalitis virus that mainly occurs in Asia. The virus is transmitted to humans by infected mosquitoes that feed on human blood. JESPECT ® is used to vaccinate persons 18 years and older • who plan to live in or travel to areas where Japanese encephalitis is common or seasonal. Your doctor will explain your individual risk of catching the disease. • who work with Japanese encephalitis virus. JESPECT ® is given as two injections 28 days apart. The vaccination course should be completed at least one week before potential exposure to the Japanese encephalitis virus. How _JESPECT_ _®_ works JESPECT ® works by getting your body to produce its own protection against the Japanese encephalitis virus. The vaccine does not contain live virus and cannot give you the illness. After you have been gi Przeczytaj cały dokument
CSL Limited JESPECT ® Product Information AUST R 150602 100920-JEV-PI-V7-clean.docx Page 1 JESPECT NAME OF THE DRUG JESPECT ® . Inactivated Japanese Encephalitis Vaccine (adsorbed), suspension for injection. DESCRIPTION JESPECT ® Japanese Encephalitis (JE) Virus, purified inactivated vaccine is a sterile, ready to use suspension for intramuscular (IM) injection. The vaccine is prepared by propagating Japanese encephalitis virus strain (SA 14 -14-2) in Vero cells. No preservatives or antibiotics are added to the formulation. JESPECT ® is a clear liquid with white precipitate and when shaken before use a white/cloudy suspension forms. JESPECT ® is supplied in pre-filled syringes without needles. Each 0.5 mL dose of vaccine contains 6 micrograms (µg) of purified, inactivated JE virus. Each dose of vaccine also contains the following excipients: 0.1% aluminium hydroxide, hydrated corresponding to 0.25 mg aluminium, and Phosphate Buffered Saline. PHARMACOLOGY Animal studies in mice, rats and rabbits have shown that the JESPECT ® vaccine induces the immune system to produce neutralising antibodies against Japanese encephalitis virus which correlate with protection and survival. Mice treated with JESPECT ® vaccine or human JESPECT ® antisera demonstrated protection against lethal Japanese encephalitis challenge from several different (SA 14 , Beijing and KE-093) strains in a generally dose- or titre-dependent manner, respectively. CLINICAL TRIALS Efficacy (immunogenicity) of JESPECT ® has been studied in approximately 2228 healthy, adult subjects in 10 multi-centre clinical trials conducted in the US and Europe. Immunogenicity of the vaccine was evaluated in a randomized, active- controlled, observer-bl Przeczytaj cały dokument